SEARCH BY
| Category | Company |
|---|---|
| Founded | 1668 |
| Sector | Diversified |
| Employees | 64,011 |
| Revenue | 21.2B EUR (2024) |
Merck is a science and technology company in healthcare, life science, and performance materials. It develops technologies that improve and enhance life, from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 24 of 26 |
| Sector: Semiconductors M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 20 of 21 |
| Country: France M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
| Size (of disclosed) | 6 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-06 |
Exelead
Indianapolis, Indiana, United States Exelead is a biopharmaceutical contract development and manufacturing organization (CDMO). Exelead is based in Indianapolis, Indiana. |
Buy | $780M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-28 |
SpringWorks Therapeutics
Stamford, Connecticut, United States SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. SpringWorks Therapeutics was founded in 2017 and is based in Stamford, Connecticut. |
Buy | $3.9B |
